Evidence map›Paper›PMID 39107514›Full record

ArticlePharmaceutical research2024

Comparison of Relative Activity versus Relative Expression Factors (RAF versus REF) in Predicting Glucuronidation Mediated Drug Clearance Using Recombinant UGTs.

Sandhya Subash, Deepak Ahire, Mitesh Patel, Sahil Shaikh, Dilip Kumar Singh, Sujal Deshmukh, Bhagwat Prasad

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Pharmaceutical research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sandhya Subash *Department of Pharmaceutical Sciences, Washington State University (WSU), Spokane, WA, 99202, USA.
Deepak Ahire *Department of Pharmaceutical Sciences, Washington State University (WSU), Spokane, WA, 99202, USA.
Mitesh PatelNovartis Institutes for BioMedical Research, Inc, Cambridge, MA, USA.
Sahil ShaikhNovartis Institutes for BioMedical Research, Inc, Cambridge, MA, USA.
Dilip Kumar SinghDepartment of Pharmaceutical Sciences, Washington State University (WSU), Spokane, WA, 99202, USA.
Sujal DeshmukhNovartis Institutes for BioMedical Research, Inc, Cambridge, MA, USA.
Bhagwat PrasadDepartment of Pharmaceutical Sciences, Washington State University (WSU), Spokane, WA, 99202, USA. bhagwat.prasad@wsu.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePredicting the quantitative fraction of glucuronidation (f

methodsREF scalars were derived from a previous in-house proteomics study for eleven UGT enzymes (UGT1A1, UGT1A3, UGT1A4, UGT1A6, UGT1A9, UGT1A10, UGT2B4, UGT2B7, UGT2B10, UGT2B15, and UGT2B17), whereas RAF was calculated by measuring activities in rUGTs to microsomes of selective UGT probe substrates. Protein-normalized activity factor (pnAF) values were generated after correcting activity of individual UGTs to their corresponding protein abundance. The utility of REF and RAF in predicting f

resultsThe REF values ranged from 0.02 to 1.75, RAF based on activity obtained in rUGTs to HLM/HIM were from 0.1 to 274. pnAF values were ~ 5 to 80-fold, except for UGT2B4 and UGT2B15, where pnAF was ~ 180 and > 1000, respectively. The results revealed confounding effect of differential specific activities (per pmol) of rUGTs in f

conclusionThe data suggest that the activity of UGT enzymes was significantly lower when compared to their activity in microsomes at the same absolute protein amount (pmol). Collectively, results of this study demonstrate poor and variable specific activity of different rUGTs (per pmol protein), as determined by pnAF values, which should be considered in f

Indexed as

GlucuronidesGlucuronosyltransferaseMicrosomes, LiverRecombinant ProteinsDiclofenacHumansIntestinal MucosaMetabolic Clearance RateMicrosomesDiclofenacGlucuronidesGlucuronosyltransferaseRecombinant Proteinsfractional contributionglucuronidationintrinsic clearanceRAFREF

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.